Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Hypertension and the Risk of Breast Cancer in Chilean Women: a Case-control Study

  • Pereira, Ana (School of Public Health, Faculty of Medicine, Universidad de Chile) ;
  • Garmendia, Maria Luisa (School of Public Health, Faculty of Medicine, Universidad de Chile) ;
  • Alvarado, Maria Elena (School of Public Health, Faculty of Medicine, Universidad de Chile) ;
  • Albala, Cecilia (Institute of Nutrition and Food Technology, Universidad de Chile)
  • Published : 2012.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Breast cancer is the most common cancer in women worldwide. Although different metabolic factors have been implicated in breast cancer development, the relationship between hypertension and breast cancer has not been elucidated. Aim: To evaluate hypertension as a risk factor for breast cancer in Chilean women of low and middle socio-economic status. Methods: We conducted an age-matched (1:1) case-control study in 3 hospitals in Santiago, Chile. Breast cancer cases (n=170) were histopathologically confirmed. Controls had been classified as Breast Imaging Reporting and Data System I (negative) or II (benign findings) within 6 months of recruitment. Blood pressure was measured using a mercury sphygmomanometer and standardized procedures. We used 2 hypertension cut-off points: blood pressures of ${\geq}140/90$ mmHg and ${\geq}130/85$ mmHg. Fasting insulin and glucose levels were assessed, and anthropometric, sociodemographic, and behavioral information were collected. Odds ratios and 95% confidence intervals were estimated for the entire sample and restricted to postmenopausal women using multivariable conditional logistic regression models. Results: Hypertension (${\geq}140/90$ mmHg) was significantly higher in cases (37.1%) than controls (17.1%) for the entire sample and in postmenopausal pairs (44.0% compared to 23.8%). In crude and adjusted models, hypertensive women had a 4-fold increased risk of breast cancer (adjusted odds ratio: 4.2; 95% confidence interval: 1.8; 9.6) compared to non-hypertensive women in the entire sample. We found a similar association in the postmenopausal group (adjusted odds ratio: 2.8; 95% confidence interval: 1.1; 7.4). A significant effect was also observed when hypertension was defined as blood pressure of ${\geq}130/85$ mmHg. Conclusion: A significant association was found between hypertension and breast cancer over the entire sample and when restricted to postmenopausal women. Hypertension is highly prevalent in Latin America and may be a modifiable risk factor for breast cancer; therefore, a small association between hypertension and breast cancer may have broad implications.

Keywords

References

  1. Agnoli C, F Berrino, CA Abagnato, et al (2009). Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis, 20, 41-8.
  2. Balkwill F, KA Charles, A Mantovani, et al (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 7, 211-7. https://doi.org/10.1016/j.ccr.2005.02.013
  3. Balleyguier C, S Ayadi, K Van Nguyen, et al (2007). BIRADS classification in mammography. Eur J Radiol, 61, 192-4. https://doi.org/10.1016/j.ejrad.2006.08.033
  4. Bjorge T, A Lukanova, H Jonsson, et al (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev, 19, 1737-45. https://doi.org/10.1158/1055-9965.EPI-10-0230
  5. Craig CL, AL Marshall, M Sjostrom, et al (2003). International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc, 35, 1381-95. https://doi.org/10.1249/01.MSS.0000078924.61453.FB
  6. Chilean Ministry of Health, SD (2008). Estadisticas Vitales. Retrieved 06/06, 2011, from http://deis.minsal.cl/deis/vitales/vita.asp.
  7. Chobanian AV, GL Bakris, HR Black, et al (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42, 1206-52. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
  8. Dubey RK, S Oparil, B Imthurn, et al (2002). Sex hormones and hypertension. Cardiovasc Res, 53, 688-708. https://doi.org/10.1016/S0008-6363(01)00527-2
  9. Ferlay J, Shin HR, F Bray, et al (2010). Available from: http://globocan.iarc.fr ). GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer.
  10. Franceschi S, C la Vecchia, E Negri, et al (1990). Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer, 26, 781-5. https://doi.org/10.1016/0277-5379(90)90151-I
  11. Garmendia ML, A Pereira, ME Alvarado, et al (2007). Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol, 17, 403-9. https://doi.org/10.1016/j.annepidem.2007.01.037
  12. Giovannucci E (1995). Insulin and colon cancer. Cancer Causes Control, 6, 164-79. https://doi.org/10.1007/BF00052777
  13. Greene FL, CC Compton, AG Fritz, et al (2006). AJCC Cancer Staging Atlas. New York, NY, Springer Science+Business Media, Inc.
  14. Greenland S, J Pearl, JM Robins, et al (1999). Causal diagrams for epidemiologic research. Epidemiology, 10, 37-48. https://doi.org/10.1097/00001648-199901000-00008
  15. Grossman E, FH Messerli, V Boyko, et al (2002). Is there an association between hypertension and cancer mortality? Am J Med, 112, 479-86. https://doi.org/10.1016/S0002-9343(02)01049-5
  16. Hamet P (1997). Cancer and hypertension: a potential for crosstalk? J Hypertens, 15, 1573-7. https://doi.org/10.1097/00004872-199715120-00058
  17. Hernan MA, S Hernandez-Diaz, MM Werler, et al (2002). Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol, 155, 176-84. https://doi.org/10.1093/aje/155.2.176
  18. Hunter DJ, WC Willett (1993). Diet, body size, and breast cancer. Epidemiol Rev, 15, 110-32. https://doi.org/10.1093/oxfordjournals.epirev.a036096
  19. Kabat GC, M Kim, RT Chlebowski, et al (2009). A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 18, 2046-53. https://doi.org/10.1158/1055-9965.EPI-09-0235
  20. Key TJ, PK Verkasalo, E Banks, et al (2001). Epidemiology of breast cancer. Lancet Oncol, 2, 133-40. https://doi.org/10.1016/S1470-2045(00)00254-0
  21. La Vecchia C, E Negri, S Franceschi, et al (1997). Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer, 75, 441-4. https://doi.org/10.1038/bjc.1997.73
  22. Largent JA, L Bernstein, PL Horn-Ross, et al (2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control, 21, 1615-24. https://doi.org/10.1007/s10552-010-9590-x
  23. Largent JA, AJ McEligot, A Ziogas, et al (2006). Hypertension, diuretics and breast cancer risk. J Hum Hypertens, 20, 727-32. https://doi.org/10.1038/sj.jhh.1002075
  24. Li CI, KE Malone, NS Weiss, et al (2003). Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer, 98, 1504-13. https://doi.org/10.1002/cncr.11663
  25. Li JJ, CH Fang, RT Hui, et al (2005). Is hypertension an inflammatory disease? Med Hypotheses, 64, 236-40. https://doi.org/10.1016/j.mehy.2004.06.017
  26. Lindgren A, E Pukkala, J Tuomilehto, et al (2007). Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer, 121, 641-4. https://doi.org/10.1002/ijc.22689
  27. Mackenzie IS, TM Macdonald, A Thompson, et al (2012). Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ, 345, 4447. https://doi.org/10.1136/bmj.e4447
  28. Madigan MP, RG Ziegler, J Benichou, et al (1995). Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst, 87, 1681-5. https://doi.org/10.1093/jnci/87.22.1681
  29. Matthews DR, JP Hosker, AS Rudenski, et al (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-9. https://doi.org/10.1007/BF00280883
  30. Ministerio de Salud (2010). Encuesta Nacional de Salud (ENS) Chile 2009-2010,. Santiago, Chile.
  31. Muti P, T Quattrin, BJ Grant, et al (2002). Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev, 11, 1361-8.
  32. National Cholesterol Education Program (NCEP) (2002). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-421.
  33. Peeters PH, PA van Noord, AW Hoes, et al (2000). Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens, 18, 249-54. https://doi.org/10.1097/00004872-200018030-00002
  34. Porter PL (2009). Global trends in breast cancer incidence and mortality. Salud Publica Mex, 51, 141-6. https://doi.org/10.1590/S0036-36342009000800003
  35. Reeves KW, V McLaughlin, L Fredman, et al (2012). Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control, 23, 1241-51. https://doi.org/10.1007/s10552-012-0002-2
  36. Robins JM (2001). Data, design, and background knowledge in etiologic inference. Epidemiology, 12, 313-20. https://doi.org/10.1097/00001648-200105000-00011
  37. Ronco AL, E De Stefani, H Deneo-Pellegrini, et al (2012). Risk factors for premenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 2879-86. https://doi.org/10.7314/APJCP.2012.13.6.2879
  38. Ronco AL, E De Stefani, H Deneo-Pellegrini, et al (2012). Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 139-46. https://doi.org/10.7314/APJCP.2012.13.1.139
  39. Rosato V, C Bosetti, R Talamini, et al (2011). Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol, 22, 2687-92. https://doi.org/10.1093/annonc/mdr025
  40. Soler M, L Chatenoud, E Negri, et al (1999). Hypertension and hormone-related neoplasms in women. Hypertension, 34, 320-5. https://doi.org/10.1161/01.HYP.34.2.320
  41. Toniolo P, PF Bruning, A Akhmedkhanov, et al (2000). Serum insulin-like growth factor-I and breast cancer. Int J Cancer, 88, 828-32. https://doi.org/10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8
  42. World Health Organization (1995). Physical status: The use and interpretation of anthropometry. WHO Technical Report Series. Geneva, WHO.
  43. Xue F, KB Michels (2007). Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr, 86, 823-35. https://doi.org/10.1093/ajcn/86.3.823S

Cited by

  1. Metabolic dysregulation and cancer mortality in a national cohort of blacks and whites vol.17, pp.1, 2017, https://doi.org/10.1186/s12885-017-3807-2
  2. Risk factors of breast cancer and knowledge about the disease: an integrative revision of Latin American studies vol.22, pp.1, 2017, https://doi.org/10.1590/1413-81232017221.09272015
  3. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies vol.40, pp.1, 2018, https://doi.org/10.1080/10641963.2017.1288736
  4. Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk vol.94, pp.16, 2015, https://doi.org/10.1097/MD.0000000000000753
  5. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype pp.1573-7217, 2018, https://doi.org/10.1007/s10549-018-5056-8
  6. Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies vol.6, pp.12, 2018, https://doi.org/10.12998/wjcc.v6.i12.483
  7. Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI vol.10, pp.9, 2018, https://doi.org/10.3390/cancers10090299